Against a backdrop of frequent, high-profile failures in late stage pharmaceutical development, the case for transformational change is clear.

Significant pipeline productivity challenges coupled with a complex quality system that bogged an eye care company down with administrative burden were also stifling innovation.

Read how Quintiles reduced R&D SOPs by 90% and worked with the customer to reorganize the business architecture to optimize performance, paving the way for innovation.